{
    "2020-11-05": [
        [
            {
                "time": "",
                "original_text": "康龙化成现2笔大宗交易 ，共成交9,062.40万元",
                "features": {
                    "keywords": [
                        "康龙化成",
                        "大宗交易",
                        "成交额"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "康龙化成(03759.HK)3Q20业绩：利润率持续提升，维持“买入”评级，目标价135.0港元",
                "features": {
                    "keywords": [
                        "康龙化成",
                        "业绩",
                        "利润率",
                        "买入评级",
                        "目标价"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "医药生物行业上市公司2020年三季报小结：疫情影响逐渐消退 关注高成长大龙头+细分冠军",
                "features": {
                    "keywords": [
                        "医药生物",
                        "三季报",
                        "疫情影响",
                        "高成长",
                        "龙头"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "【异动股】康龙化成(03759-HK)涨3.42%",
                "features": {
                    "keywords": [
                        "康龙化成",
                        "股价上涨",
                        "异动"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "快讯：港股医药股集体上涨 药明巨诺涨超8%康龙化成涨近5%",
                "features": {
                    "keywords": [
                        "港股",
                        "医药股",
                        "集体上涨",
                        "药明巨诺",
                        "康龙化成"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "商业模式：「里程碑」付款模式和「风险共担，利益共享」模式为主",
                "features": {
                    "keywords": [
                        "商业模式",
                        "里程碑",
                        "风险共担",
                        "利益共享"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            }
        ]
    ]
}